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ABSTRACT
We encountered two patients with severe cow’s milk allergy who reacted strongly to an injection of methylpred-
nisolone sodium succinate (Sol-Medrol 40 mgⓇ Pfizer, Japan). They came to our hospital because of an asth-
matic attack or urticaria and were treated with Sol-Medrol 40 mgⓇ. After the injection, the allergic reaction was
immediate. Skin prick tests demonstrated that the β-lactoglobulin contaminating the lactose of the drug prepa-
ration caused the immediate allergic reaction.
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INTRODUCTION
Patients who have food allergies need to pay particu-
lar attention to their intake not only of foods but also
of pharmaceutical drugs. Usually, it is comparatively
safe for children with milk allergies to ingest drugs
containing lactose, but not if the lactose is contami-
nated with milk protein.
Methylprednisolone sodium succinate (Sol-MedrolⓇ)
is frequently used for allergic patients in Japan. When
a methylprednisolone sodium succinate injection is
administered to children with exacerbation of bron-
chial asthma or with an allergic predisposition, 40 mg
of the drug is usually used, since this is the minimum
dose. Pharmacists produce 4 different doses of meth-
ylprednisolone sodium succinate, and lactose is found
only in the 40 mg preparation (25 mg of lactose per
vial).
In this report, we describe two cases of severe milk
allergy in which an immediate allergic reaction due to
the lactose in Sol-Medrol 40 mgⓇ was diagnosed.
CLINICAL SUMMARY
CASE 1
An 8-year-old girl was referred to the Emergency De-
partment at Fujisawa City Hospital in September 2006
because of a high fever, cough and wheezing.
In early childhood, she was diagnosed as having
bronchial asthma, atopic dermatitis and a food al-
lergy, and was instructed to avoid consuming milk,
buckwheat, beef, and processed foods containing
these. It is uncertain whether the patient had epi-
sodes of anaphylaxis due to food allergy.
Acute bronchitis and a moderate asthmatic attack
were diagnosed. β2-agonist inhalation was not effec-
tive, and therefore a 30 mg injection of Sol-Medrol 40
mgⓇ was administered. This was followed by the
rapid spread of urticaria all over her body.
We attributed this to an allergic reaction to the
medicine. When the patient was given hydroxyzine
hydrochloride intravenously and a hypodermic injec-
tion of epinephrine, her condition improved immedi-
ately.
CASE 2
A 3-year-old boy was referred to the Emergency De-
partment of Fujisawa City Hospital in September 2006
because of urticaria in the neck. He had allergies to
various plants and had had episodes of anaphylaxis at
2 years of age due to exposure to some plants. He
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Table 1 Results of skin prick test in Case 1
Serum Specific IgESPT＊
＞100 UA/ml＋＋Milk
13.4 UA/ml＋＋Egg white
ND＋＋Egg yolk
2.93 UA/ml－Soybean
3.57 UA/ml－Wheat
3.53 UA/ml＋Buckwheat
0.34 UA/mlND＊＊Beef
＞100 UA/mlNDDermatophagoides 
pteronyssinus
＞100 UA/mlNDHouse dust
17.3 UA/mlNDAlternaria
ND＋＋Japanese cedar polen
ND＋Sol-Medrol 40 mgⓇ
ND－Sol-Medrol 125 mgⓇ
ND－DecadroneⓇ
ND－Solu-CortefⓇ
ND－PredonineⓇ
SPT＊: Skin prick test, ND＊＊: NOT DONE.
also had food allergies and avoided consuming milk,
egg, soybean, sesame, peanut, shrimp, and crab. He
had no history of anaphylaxis due to food allergy and
had no symptoms when he ate cornflakes containing
lactose when he was 3 years of age.
The urticaria appeared when he took a walk
around a park which had a variety of plants. He had
no complaints of cough, nasal discharge, or eye
symptoms. He came to the hospital after having taken
hydroxyzine hydrochloride. There was urticaria on
his neck, although he had no respiratory distress,
and his general condition was not poor. He was diag-
nosed with an acute allergic reaction to some plants,
and 20 mg of Sol-Medrol 40 mgⓇ was injected. After
that, rash and urticaria spread rapidly all over his
body.
We suspected that the rash was caused by the in-
jection of Sol-Medrol 40 mgⓇ, and therefore we ad-
ministered hydroxyzine hydrochloride intravenously.
The rash improved immediately.
LABORATORY FINDINGS
The laboratory data in Case 1 showed an abnormal in-
crease in leukocytes and C reactive protein because
of acute bronchitis (white blood cell count 15,800
mm3, C-reactive protein 0.9 mgdl). Serum total IgE
antibody was 1610 UAmL and serum-specific cow’s
milk-IgE was over 100 UAmL. (Serum-specific IgE
antibody was measured with the Phadia CAP RAST
system, Phadia diagnostics; the lower limit of detec-
tion was 0.35 UAmL and the upper limit of detection
was 100 UAmL).
The laboratory data in Case 2 were normal except
that serum-specific milk-IgE was over 100 UAmL.
Serum total IgE was 13000 UAmL in 2005.
We hypothesized that Sol-Medrol 40 mgⓇ was the
cause of the allergic reactions and performed skin
prick tests on both of these patients after their symp-
toms stabilized.
METHODS
On the basis of the patients’ histories, we used anti-
genic liquid (Torii, Japan) and administered the fol-
lowing five steroids for injection: methylprednisolone
sodium succinate (Sol-Medrol 40 mgⓇ), methylpred-
nisolone sodium succinate (Sol-Medrol 125 mgⓇ),
hydrocortisone sodium succinate (Solu-Cortef 100
mgⓇ), dexamethasone (Decadron 2 mgⓇ), and pred-
nisolone sodium succinate (Predonine 10 mgⓇ). Only
methylprednisolone sodium succinate (Sol-Medrol 40
mgⓇ) contained lactose.
For Case 2, we also tested for lactose produced as
described in the Japanese Pharmacopoeia.
The needles used for the prick tests were standard,
regularly used, bifurcated needles made by ALO
Laboratories, Inc (OH, USA). Results were consid-
ered strongly positive if the resulting wheal meas-
ured 10 mm or more in diameter, and positive if it
was 5 mm or more in diameter, or was at least twice
the size of the reaction to the control.
We also examined whether the milk protein was
contained in Sol-Medrol 40 mgⓇ and 1 g of lactose
produced according to the Japanese Pharmacopoeia.
We performed a quantitative analysis of β-
lactoglobulin with the Morinaga specific material
measurement kit at Doshisha Women’s College of
Liberal Arts.
RESULTS
In Case 1, strongly positive results were obtained for
milk, while a positive result was obtained for Sol-
Medrol 40 mgⓇ, and a negative one for Sol-Medrol
125 mg (Table 1).
In Case 2, the results were strongly positive for
milk and lactose, positive for Sol-Medrol 40 mgⓇ, and
negative for Sol-Medrol 125 mgⓇ. The reason why
the test for Predonine was positive is unknown (Table
2).
The results of a quantitative analysis of β-
lactoglobulin are shown in Table 3. β-lactoglobulin
was detected in Sol-Medrol 40 mgⓇ (112.5 ng of β-
lactoglobulin per vial), and lactose (1.35 μg of β-
lactoglobulin per gram of lactose).
DISCUSSION
From the results of skin prick tests and the quantita-
tive analysis of β-lactoglobulin, we concluded that the
lactose in Sol-Medrol 40 mgⓇ was contaminated by
milk protein and caused immediate allergic reactions
in the two cases. Especially in Case 1, it is possible
that acute bronchitis played a part in the allergic reac-
tion. In 2002, Morishita et al. reported that anaphy-
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Table 2 Result of skin prick test in Case 2
Serum Specific IgESPT
＞100 UA/ml＋＋Milk
＞100 UA/ml＋＋Egg white
31.1 UA/ml＋＋Egg yolk
19 UA/ml＋＋Ovomucoid
27.3 UA/ml＋＋Wheat
ND＋＋Soybean
ND＋＋Shrimp
ND＋＋Buckwheat
11.3 UA/mlNDCypress
27.4 UA/mlNDOrchard grass
44.5 UA/mlNDRagweed
17.3 UA/mlNDMugwort
29 UA/mlNDGolden rod
ND＋＋Lactose
ND＋Sol-Medrol 40 mgⓇ
ND－Sol-Medrol 125 mgⓇ
ND－DecadroneⓇ
ND－Solu-CortefⓇ
ND＋PredonineⓇ
Table 3 Quantitative analysis of β-lactoglobulin
β-lactoglobulin
112.5 ng/vialSol-Medrol 40 mg
1.35 μg/gLactose
laxis due to lactose in Sol-Medrol 40 mgⓇ was diag-
nosed in a 4-year-old Japanese boy who had cow’s
milk allergy.1 The authors performed skin prick tests
on the patient and obtained a positive result for Sol-
Medrol 40 mgⓇ and a negative result for Sol-Medrol
125 mgⓇ. These results matched those in our two
cases.
We ascertained that the lactose produced as de-
scribed in the Japanese Pharmacopoeia contains milk
protein as a result of imperfect purification. Accord-
ing to the manual of the Japanese Pharmacopoeia
concerning lactose,2 the protein mixture is expected
to be eliminated during the manufacturing process,
and there is no possibility for milk protein to be pre-
sent in the lactose. Therefore, the product informa-
tion inserts do not caution patients with milk allergy
about the possibility of an allergic reaction to milk
proteins.
Fiocchi et al. performed skin prick tests for lactose
in 24 patients with cow’s milk allergy, and found that
the prick tests were negative in all the patients, al-
though 13 of them had a medical history of anaphy-
laxis and the mean of their serum cow’s milk specific-
IgE concentrations was 25.7 UAml.3 He concluded
that even children with cow’s milk allergy were clini-
cally tolerant of lactose and could safely consume
foods and drugs containing it. However, we would
suggest that the results of their skin prick tests may
have been affected by lower specific IgE levels than
was observed in our two patients.
If the lactose for ingestion contains β-lactoglobulin,
it is usually safe for children with milk allergy be-
cause the lactose passes through the immune portion
of the digestive system. However, when a small
amount of β-lactoglobulin is injected directly, it is
bound to cause an allergic reaction in sensitive pa-
tients. Moreover, the lactose in Sol-Medrol 40 mgⓇ is
at a higher concentration than that determined by a
quantitative analysis of β-lactoglobulin according to
the Japanese Pharmacopoeia, as shown in Table 3.
This is a very important fact for both the patient and
physician.
Lactose is commonly used as an inactive ingredient
in many pharmaceutical formulations including tab-
lets, suspensions, dry powder inhalers, and medi-
cines for injection. A previous report described a
cow’s milk allergy in an asthmatic patient who had an
anaphylactic reaction to the milk protein in a dry pow-
der inhaler containing both salmeterol and flutica-
sone.4
In conclusion, when a patient with severe cow’s
milk allergy is treated with a drug, especially when
that drug is intravenously injected, only a preparation
entirely free of lactose should be used. Although
drug additives such as lactose are necessary for stabi-
lization or activation of the constituents of prepara-
tions, the fact that some additives cause severe aller-
gic reactions must be constantly borne in mind.
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